FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Clinical trial NCT06917313 · RECRUITING

Trial details

NCT number: NCT06917313
Sponsor: Yale University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Start date: 2025-12-05
Primary completion: 2028-03-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.